Amarin (AMRN)
(Delayed Data from NSDQ)
$0.64 USD
+0.01 (1.35%)
Updated Aug 26, 2024 04:00 PM ET
After-Market: $0.64 0.00 (0.46%) 7:58 PM ET
3-Hold of 5 3
B Value A Growth A Momentum A VGM
Earnings News For AMRN
-
Amarin (AMRN) Stock Down Despite Q2 Earnings & Revenues Beat
-
Amarin Reports Second Quarter 2024 Financial Results and Provides Business Update
-
Amarin's (AMRN) Q1 Earnings and Revenues Surpass Estimates
-
Amarin: Q1 Earnings Snapshot
-
Amarin Reports First Quarter 2024 Business Update and Financial Results
-
Amarin's (AMRN) Q4 Earnings and Revenues Surpass Estimates
-
Amarin: Q4 Earnings Snapshot
-
Amarin: Q4 Earnings Snapshot
-
Amarin Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
-
Amarin (AMRN) Q3 Earnings and Revenues Surpass Estimates
-
Amarin: Q3 Earnings Snapshot
-
Amarin Reports Third Quarter 2023 Financial Results
-
Amarin (AMRN) Q2 Earnings and Revenues Surpass Estimates
-
Amarin: Q2 Earnings Snapshot
-
Amarin Reports Second Quarter 2023 Financial Results
-
Amarin's (AMRN) Q1 Earnings Top, Vascepa Sales Fall
-
Amarin: Q1 Earnings Snapshot
-
Amarin Reports First Quarter 2023 Financial Results and Provides Business Update
-
Amarin's (AMRN) Q4 Earnings and Revenues Beat Estimates
-
Amarin: Q4 Earnings Snapshot
-
Amarin Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
-
Amarin (AMRN) Q3 Earnings Beat, Sales Hurt by Vascepa Generics
-
Amarin: Q3 Earnings Snapshot
-
Amarin Reports Third Quarter 2022 Financial Results and Provides Business Update
-
Amarin (AMRN) Q2 Earnings & Sales Hurt by Vazkepa Generics